Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESULT study of 1 L versus 2 L bowel preparation before colonoscopy
NL-OMON52176Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- May 2022
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
Randomised, open-label trial in colorectal cancer (CRC) comparing Pleinvue low-volume bowel preparation with Moviprep high-volume bowel preparation (2 arms). Primary endpoints: Boston Bowel Preparation Score total, Boston Bowel Preparation Score per segment and 1 more. Started May 2022; status: active, not recruiting.
02
Drugs
polyethylene glycol + electrolytes + ascorbic acidmacrogol
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NL-OMON52176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52176.